Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS – Get Rating ) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 200,200 shares, a growth of 16.9% from the February 28th total of 171,200 shares. Based on an average trading volume of 96,600 shares, the short-interest ratio is currently 2.1 days. Currently, 0.6% of the shares of the stock are short sold. Corvus Pharmaceuticals Stock Performance Corvus Pharmaceuticals stock traded up $0.

https://www.dailypolitical.com/2023/04/01/corvus-pharmaceuticals-inc-nasdaqcrvs-sees-large-increase-in-short-interest.html

#dailypolitical